Barbara Thaler
Boehringer Ingelheim (Germany)(DE)
Publications by Year
Research Areas
Protease and Inhibitor Mechanisms, Immune cells in cancer, Cell Adhesion Molecules Research, Extracellular vesicles in disease, Cardiac Fibrosis and Remodeling
Most-Cited Works
- → THE EFFECTS OF A COMPANION ANIMAL ON DISTRESS IN CHILDREN UNDERGOING DENTAL PROCEDURES(2001)116 cited
- → Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans(2016)85 cited
- → IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets(2017)43 cited
- → Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia(2018)42 cited
- → PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent(2017)33 cited
- → miR-128 regulates non-myocyte hyperplasia, deposition of extracellular matrix and Islet1 expression during newt cardiac regeneration(2013)33 cited
- → CD4+CD28null T Lymphocytes are Associated with the Development of Atrial Fibrillation after Elective Cardiac Surgery(2018)28 cited
- → Differential expression of Plg-RKT and its effects on migration of proinflammatory monocyte and macrophage subsets(2019)26 cited
- → Alternative activation of human macrophages enhances tissue factor expression and production of extracellular vesicles(2020)23 cited
- → Urokinase plasminogen activator protects cardiac myocytes from oxidative damage and apoptosis via hOGG1 induction(2017)23 cited